Human Xtensions Stock Fundamentals
| HUMX Stock | ILA 29.10 0.20 0.69% |
Human Xtensions fundamentals help investors to digest information that contributes to Human Xtensions' financial success or failures. It also enables traders to predict the movement of Human Stock. The fundamental analysis module provides a way to measure Human Xtensions' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Human Xtensions stock.
Human |
Human Xtensions Company Operating Margin Analysis
Human Xtensions' Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Current Human Xtensions Operating Margin | (14.93) % |
Most of Human Xtensions' fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Human Xtensions is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
| Competition |
Based on the recorded statements, Human Xtensions has an Operating Margin of -14.9251%. This is 57.45% lower than that of the Healthcare sector and 62.03% lower than that of the Medical Devices industry. The operating margin for all Israel stocks is 170.87% higher than that of the company.
Human Xtensions Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Human Xtensions's current stock value. Our valuation model uses many indicators to compare Human Xtensions value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Human Xtensions competition to find correlations between indicators driving Human Xtensions's intrinsic value. More Info.Human Xtensions is rated # 2 in return on equity category among its peers. It also is rated # 2 in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Human Xtensions by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Human Xtensions' Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Human Operating Margin Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Human Xtensions' direct or indirect competition against its Operating Margin to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Human Xtensions could also be used in its relative valuation, which is a method of valuing Human Xtensions by comparing valuation metrics of similar companies.Human Xtensions is one of the top stocks in operating margin category among its peers.
Human Fundamentals
| Return On Equity | -0.5 | |||
| Return On Asset | -0.27 | |||
| Operating Margin | (14.93) % | |||
| Current Valuation | (47.61 M) | |||
| Shares Outstanding | 26.76 M | |||
| Shares Owned By Insiders | 55.22 % | |||
| Shares Owned By Institutions | 9.62 % | |||
| Price To Book | 0.27 X | |||
| Price To Sales | 6.20 X | |||
| Revenue | 3.12 M | |||
| Gross Profit | 1.62 M | |||
| EBITDA | (45.95 M) | |||
| Net Income | (28.54 M) | |||
| Cash And Equivalents | 148.31 M | |||
| Cash Per Share | 5.56 X | |||
| Total Debt | 7.55 M | |||
| Debt To Equity | 0.05 % | |||
| Current Ratio | 16.84 X | |||
| Book Value Per Share | 2.67 X | |||
| Cash Flow From Operations | (27.26 M) | |||
| Earnings Per Share | (2.01) X | |||
| Number Of Employees | 72 | |||
| Beta | 1.26 | |||
| Market Capitalization | 28.63 M | |||
| Z Score | 1.8 |
About Human Xtensions Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Human Xtensions's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Human Xtensions using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Human Xtensions based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.It offers HandX, a handheld medical device for use in laparoscopic procedures. The company was founded in 2012 and is based in Netanya, Israel. HUMAN XTENSIONS operates under Medical Devices classification in Israel and is traded on Tel Aviv Stock Exchange. It employs 58 people.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Human Stock
Human Xtensions financial ratios help investors to determine whether Human Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Human with respect to the benefits of owning Human Xtensions security.